Literature DB >> 11360182

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

C P Paweletz1, L Charboneau, V E Bichsel, N L Simone, T Chen, J W Gillespie, M R Emmert-Buck, M J Roth, E F Petricoin III, L A Liotta.   

Abstract

Protein arrays are described for screening of molecular markers and pathway targets in patient matched human tissue during disease progression. In contrast to previous protein arrays that immobilize the probe, our reverse phase protein array immobilizes the whole repertoire of patient proteins that represent the state of individual tissue cell populations undergoing disease transitions. A high degree of sensitivity, precision and linearity was achieved, making it possible to quantify the phosphorylated status of signal proteins in human tissue cell subpopulations. Using this novel protein microarray we have longitudinally analysed the state of pro-survival checkpoint proteins at the microscopic transition stage from patient matched histologically normal prostate epithelium to prostate intraepithelial neoplasia (PIN) and then to invasive prostate cancer. Cancer progression was associated with increased phosphorylation of Akt (P<0.04), suppression of apoptosis pathways (P<0.03), as well as decreased phosphorylation of ERK (P<0.01). At the transition from histologically normal epithelium to PIN we observed a statistically significant surge in phosphorylated Akt (P<0.03) and a concomitant suppression of downstream apoptosis pathways which proceeds the transition into invasive carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360182     DOI: 10.1038/sj.onc.1204265

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  227 in total

1.  Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.

Authors:  Martin J Romeo; John Wunderlich; Lien Ngo; Steven A Rosenberg; Seth M Steinberg; David M Berman
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

2.  Protocadherin-PC promotes androgen-independent prostate cancer cell growth.

Authors:  Stephane Terry; Luis Queires; Sixtina Gil-Diez-de-Medina; Min-Wei Chen; Alexandre de la Taille; Yves Allory; Phuong-Lan Tran; Claude C Abbou; Ralph Buttyan; Francis Vacherot
Journal:  Prostate       Date:  2006-07-01       Impact factor: 4.104

Review 3.  Proteomics for protein expression profiling in neuroscience.

Authors:  Willard M Freeman; Scott E Hemby
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 4.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

5.  [Update on protein analysis of fixed tissues].

Authors:  K-F Becker; D Berg; K Malinowsky; C Wolff; B Ergin; S Meding; A Walch; H Höfler
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

6.  [Analysis of signalling pathways in formalin-fixed breast cancer tissues].

Authors:  D Berg; H Bronger; A Walch; H Höfler; K-F Becker
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

7.  Targetable T-type Calcium Channels Drive Glioblastoma.

Authors:  Ying Zhang; Nichola Cruickshanks; Fang Yuan; Baomin Wang; Mary Pahuski; Julia Wulfkuhle; Isela Gallagher; Alexander F Koeppel; Sarah Hatef; Christopher Papanicolas; Jeongwu Lee; Eli E Bar; David Schiff; Stephen D Turner; Emanuel F Petricoin; Lloyd S Gray; Roger Abounader
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

8.  Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.

Authors:  A Jasper Nijdam; Michael R Zianni; Edward E Herderick; Mark M-C Cheng; Jenifer R Prosperi; Fredika A Robertson; Emanuel F Petricoin; Lance A Liotta; Mauro Ferrari
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

9.  Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.

Authors:  Ying Zhang; Kaitlyn E Farenholtz; Yanzhi Yang; Fadila Guessous; Charles G Dipierro; Valerie S Calvert; Jianghong Deng; David Schiff; Wenjun Xin; Jae K Lee; Benjamin Purow; James Christensen; Emanuel Petricoin; Roger Abounader
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

10.  Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Authors:  Rehan Akbani; Karl-Friedrich Becker; Neil Carragher; Ted Goldstein; Leanne de Koning; Ulrike Korf; Lance Liotta; Gordon B Mills; Satoshi S Nishizuka; Michael Pawlak; Emanuel F Petricoin; Harvey B Pollard; Bryan Serrels; Jingchun Zhu
Journal:  Mol Cell Proteomics       Date:  2014-04-28       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.